IL17A and psoriasis: Pathologically, psoriasis is associated with an increase in the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukins (IL-1 and IL-17), and interferon-γ (IFN-γ), that drive the development of the disease.